SlideShare a Scribd company logo
1 of 15
HIV/AIDS in prisons:  A review of the international evidence Winnipeg, 23 November 2009 Ralf Jürgens, consultant
Acknowledgements ,[object Object],[object Object],[object Object]
Background ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Background ,[object Object],[object Object],[object Object]
HIV prevalence in selected countries ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Injecting & needle sharing in prison
Review of the evidence ,[object Object],[object Object],[object Object],[object Object]
Education and information ,[object Object],[object Object],[object Object],[object Object]
Needle and syringe programmes ,[object Object],[object Object],[object Object],[object Object]
Evidence NSPs (Stöver & Nelles, 2003;  Stark et al., 2005;  Rutter et al., 2001) Prison Incidence HIV&HCV Needle sharing Drug use Injecting Am Hasenburg (D) No increase No increase Basauri (Es) No HIV No increase No increase Hannoversand (D) No increase No increase Hindelbank (CH) No HIV Decrease No increase Lehrter Strasse & Lichtenburg (D) No HIV but HCV No increase No increase Linger 1 (D) No HIV No increase No increase Realta (CH) No HIV Single cases Decrease No increase Vechta (D) No HIV No increase No increase Vierlande (D) No HIV Little change or reduction No increase No increase
Evidence NSPs  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Recommendations NSPs  ,[object Object],[object Object],[object Object],[object Object]
Bleach and decontamination strategies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Drug demand & supply reduction measures ,[object Object],[object Object],[object Object],[object Object]
Conclusion: From evidence to action ,[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

7. hcv treatment for pwid final
7. hcv treatment for pwid final7. hcv treatment for pwid final
7. hcv treatment for pwid finalantoine piaton
 
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...ReShape
 
Interphone and beyond evidence for harm or safety armstrong
Interphone and beyond evidence for harm or safety  armstrongInterphone and beyond evidence for harm or safety  armstrong
Interphone and beyond evidence for harm or safety armstrongLeishman Associates
 
HIV self-testing among transgender women in San Francisco - a pilot
HIV self-testing among transgender women in San Francisco - a pilotHIV self-testing among transgender women in San Francisco - a pilot
HIV self-testing among transgender women in San Francisco - a pilotCheryl Johnson
 
Zimbabwe HIV Self-testing presentation
Zimbabwe HIV Self-testing presentationZimbabwe HIV Self-testing presentation
Zimbabwe HIV Self-testing presentationSlidesShare_Foxtrot
 
HIV self-testing and linkage in Africa
HIV self-testing and linkage in AfricaHIV self-testing and linkage in Africa
HIV self-testing and linkage in AfricaCheryl Johnson
 
HIV self-testing in MSM
HIV self-testing in MSMHIV self-testing in MSM
HIV self-testing in MSMCheryl Johnson
 
Capstone PPT Koranda 2014 1115AM
Capstone PPT Koranda 2014 1115AMCapstone PPT Koranda 2014 1115AM
Capstone PPT Koranda 2014 1115AMLindsay Coffman
 
Mahoney UH Presentation Jan 2015
Mahoney UH Presentation Jan 2015Mahoney UH Presentation Jan 2015
Mahoney UH Presentation Jan 2015Richard Mahoney
 
novel scientific methods and technology in the reproductive medicine-global-j...
novel scientific methods and technology in the reproductive medicine-global-j...novel scientific methods and technology in the reproductive medicine-global-j...
novel scientific methods and technology in the reproductive medicine-global-j...Peertechz Publications
 
Assessment of the level of awareness on AIDS/HIV in Johor, Malaysia
Assessment of the level of awareness on AIDS/HIV in Johor, MalaysiaAssessment of the level of awareness on AIDS/HIV in Johor, Malaysia
Assessment of the level of awareness on AIDS/HIV in Johor, MalaysiaSriramNagarajan17
 
The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015Cheryl Johnson
 

What's hot (20)

Facilitating HIV testing and linkage to care - the UK experience
Facilitating HIV testing and linkage to care - the UK experienceFacilitating HIV testing and linkage to care - the UK experience
Facilitating HIV testing and linkage to care - the UK experience
 
Importance of HIV testing and linkage to care
Importance of HIV testing and linkage to careImportance of HIV testing and linkage to care
Importance of HIV testing and linkage to care
 
Vaccination in the EU, ENVI Committee, European Parliament 17 June 2015
Vaccination in the EU, ENVI Committee, European Parliament 17 June 2015Vaccination in the EU, ENVI Committee, European Parliament 17 June 2015
Vaccination in the EU, ENVI Committee, European Parliament 17 June 2015
 
7. hcv treatment for pwid final
7. hcv treatment for pwid final7. hcv treatment for pwid final
7. hcv treatment for pwid final
 
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
 
Interphone and beyond evidence for harm or safety armstrong
Interphone and beyond evidence for harm or safety  armstrongInterphone and beyond evidence for harm or safety  armstrong
Interphone and beyond evidence for harm or safety armstrong
 
HIV self-testing among transgender women in San Francisco - a pilot
HIV self-testing among transgender women in San Francisco - a pilotHIV self-testing among transgender women in San Francisco - a pilot
HIV self-testing among transgender women in San Francisco - a pilot
 
Zimbabwe HIV Self-testing presentation
Zimbabwe HIV Self-testing presentationZimbabwe HIV Self-testing presentation
Zimbabwe HIV Self-testing presentation
 
HIV self-testing and linkage in Africa
HIV self-testing and linkage in AfricaHIV self-testing and linkage in Africa
HIV self-testing and linkage in Africa
 
HIV: Reaching the 90-90-90 targets in europe
HIV: Reaching the 90-90-90 targets in europeHIV: Reaching the 90-90-90 targets in europe
HIV: Reaching the 90-90-90 targets in europe
 
HIV self-testing in MSM
HIV self-testing in MSMHIV self-testing in MSM
HIV self-testing in MSM
 
Capstone PPT Koranda 2014 1115AM
Capstone PPT Koranda 2014 1115AMCapstone PPT Koranda 2014 1115AM
Capstone PPT Koranda 2014 1115AM
 
Dr. Ameet Dravid CV
Dr. Ameet Dravid CVDr. Ameet Dravid CV
Dr. Ameet Dravid CV
 
Mahoney UH Presentation Jan 2015
Mahoney UH Presentation Jan 2015Mahoney UH Presentation Jan 2015
Mahoney UH Presentation Jan 2015
 
Novel 5-step program for reducing substance abuse related problems byintegrat...
Novel 5-step program for reducing substance abuse related problems byintegrat...Novel 5-step program for reducing substance abuse related problems byintegrat...
Novel 5-step program for reducing substance abuse related problems byintegrat...
 
5
55
5
 
novel scientific methods and technology in the reproductive medicine-global-j...
novel scientific methods and technology in the reproductive medicine-global-j...novel scientific methods and technology in the reproductive medicine-global-j...
novel scientific methods and technology in the reproductive medicine-global-j...
 
Vaccine hesitancy in the EU: state of play and impact on vaccination programmes
Vaccine hesitancy in the EU: state of play and impact on vaccination programmes	Vaccine hesitancy in the EU: state of play and impact on vaccination programmes
Vaccine hesitancy in the EU: state of play and impact on vaccination programmes
 
Assessment of the level of awareness on AIDS/HIV in Johor, Malaysia
Assessment of the level of awareness on AIDS/HIV in Johor, MalaysiaAssessment of the level of awareness on AIDS/HIV in Johor, Malaysia
Assessment of the level of awareness on AIDS/HIV in Johor, Malaysia
 
The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015
 

Similar to HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Global HIV cohort studies among IDU and future vaccine trials
Global HIV cohort studies among IDU and future vaccine trialsGlobal HIV cohort studies among IDU and future vaccine trials
Global HIV cohort studies among IDU and future vaccine trialsThira Woratanarat
 
Generic Presentation Of Data Hub
Generic Presentation Of Data HubGeneric Presentation Of Data Hub
Generic Presentation Of Data HubMichel Carael
 
Family Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MSFamily Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MSNikole Gettings
 
Bending the Curve: PrEP for HIV Prevention
Bending the Curve: PrEP for HIV PreventionBending the Curve: PrEP for HIV Prevention
Bending the Curve: PrEP for HIV PreventionHopkinsCFAR
 
8. hepatitis c prevention in hr for pwid final
8. hepatitis c prevention in hr for pwid final8. hepatitis c prevention in hr for pwid final
8. hepatitis c prevention in hr for pwid finalantoine piaton
 
HIVST and PrEP community consultation
HIVST and PrEP community consultationHIVST and PrEP community consultation
HIVST and PrEP community consultationCarmen Figueroa
 
A basic understanding of HIV surveillance
A basic understanding of HIV surveillanceA basic understanding of HIV surveillance
A basic understanding of HIV surveillanceDr.RAJEEV KASHYAP
 
PITC Presentation by MSD
PITC Presentation by MSDPITC Presentation by MSD
PITC Presentation by MSDfreespirit7
 
HPG PrEP Presentation by Dr. Kathleen Brady (AACO)
HPG PrEP Presentation by Dr. Kathleen Brady (AACO)HPG PrEP Presentation by Dr. Kathleen Brady (AACO)
HPG PrEP Presentation by Dr. Kathleen Brady (AACO)Office of HIV Planning
 
It’s Time for PrEP (Kathleen Brady, Philadelphia Department of Public Health)
It’s Time for PrEP (Kathleen Brady, Philadelphia Department of Public Health)It’s Time for PrEP (Kathleen Brady, Philadelphia Department of Public Health)
It’s Time for PrEP (Kathleen Brady, Philadelphia Department of Public Health)Office of HIV Planning
 
guidelinesmeasuringpopulation
guidelinesmeasuringpopulationguidelinesmeasuringpopulation
guidelinesmeasuringpopulationVelma Lopez
 

Similar to HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens (20)

NSP in Prisons:a brief overview…
NSP in Prisons:a brief overview…NSP in Prisons:a brief overview…
NSP in Prisons:a brief overview…
 
Global HIV cohort studies among IDU and future vaccine trials
Global HIV cohort studies among IDU and future vaccine trialsGlobal HIV cohort studies among IDU and future vaccine trials
Global HIV cohort studies among IDU and future vaccine trials
 
PrEP: Research update and implementation program in NSW
PrEP: Research update and implementation program in NSWPrEP: Research update and implementation program in NSW
PrEP: Research update and implementation program in NSW
 
Access to care for hiv infected pwid what can be done
Access to care for hiv infected pwid  what can be doneAccess to care for hiv infected pwid  what can be done
Access to care for hiv infected pwid what can be done
 
Generic Presentation Of Data Hub
Generic Presentation Of Data HubGeneric Presentation Of Data Hub
Generic Presentation Of Data Hub
 
Estimates of four sexually transmitted infections, 2016
Estimates of four sexually transmitted infections, 2016 Estimates of four sexually transmitted infections, 2016
Estimates of four sexually transmitted infections, 2016
 
Family Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MSFamily Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MS
 
Bending the Curve: PrEP for HIV Prevention
Bending the Curve: PrEP for HIV PreventionBending the Curve: PrEP for HIV Prevention
Bending the Curve: PrEP for HIV Prevention
 
8. hepatitis c prevention in hr for pwid final
8. hepatitis c prevention in hr for pwid final8. hepatitis c prevention in hr for pwid final
8. hepatitis c prevention in hr for pwid final
 
Journal.pone.0035278
Journal.pone.0035278Journal.pone.0035278
Journal.pone.0035278
 
Journal.pone.0035278
Journal.pone.0035278Journal.pone.0035278
Journal.pone.0035278
 
HIVST and PrEP community consultation
HIVST and PrEP community consultationHIVST and PrEP community consultation
HIVST and PrEP community consultation
 
One
OneOne
One
 
A basic understanding of HIV surveillance
A basic understanding of HIV surveillanceA basic understanding of HIV surveillance
A basic understanding of HIV surveillance
 
Antiretroviral therapy as HIV prevention in gay me
Antiretroviral therapy as HIV prevention in gay meAntiretroviral therapy as HIV prevention in gay me
Antiretroviral therapy as HIV prevention in gay me
 
PITC Presentation by MSD
PITC Presentation by MSDPITC Presentation by MSD
PITC Presentation by MSD
 
HPG PrEP Presentation by Dr. Kathleen Brady (AACO)
HPG PrEP Presentation by Dr. Kathleen Brady (AACO)HPG PrEP Presentation by Dr. Kathleen Brady (AACO)
HPG PrEP Presentation by Dr. Kathleen Brady (AACO)
 
It’s Time for PrEP (Kathleen Brady, Philadelphia Department of Public Health)
It’s Time for PrEP (Kathleen Brady, Philadelphia Department of Public Health)It’s Time for PrEP (Kathleen Brady, Philadelphia Department of Public Health)
It’s Time for PrEP (Kathleen Brady, Philadelphia Department of Public Health)
 
guidelinesmeasuringpopulation
guidelinesmeasuringpopulationguidelinesmeasuringpopulation
guidelinesmeasuringpopulation
 
Fsrh hc hiv phillips
Fsrh hc hiv phillipsFsrh hc hiv phillips
Fsrh hc hiv phillips
 

Recently uploaded

9548086042 for call girls in Indira Nagar with room service
9548086042  for call girls in Indira Nagar  with room service9548086042  for call girls in Indira Nagar  with room service
9548086042 for call girls in Indira Nagar with room servicediscovermytutordmt
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajanpragatimahajan3
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...Sapna Thakur
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...fonyou31
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfchloefrazer622
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 

Recently uploaded (20)

9548086042 for call girls in Indira Nagar with room service
9548086042  for call girls in Indira Nagar  with room service9548086042  for call girls in Indira Nagar  with room service
9548086042 for call girls in Indira Nagar with room service
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 

HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

  • 1. HIV/AIDS in prisons: A review of the international evidence Winnipeg, 23 November 2009 Ralf Jürgens, consultant
  • 2.
  • 3.
  • 4.
  • 5.
  • 6. Injecting & needle sharing in prison
  • 7.
  • 8.
  • 9.
  • 10. Evidence NSPs (Stöver & Nelles, 2003; Stark et al., 2005; Rutter et al., 2001) Prison Incidence HIV&HCV Needle sharing Drug use Injecting Am Hasenburg (D) No increase No increase Basauri (Es) No HIV No increase No increase Hannoversand (D) No increase No increase Hindelbank (CH) No HIV Decrease No increase Lehrter Strasse & Lichtenburg (D) No HIV but HCV No increase No increase Linger 1 (D) No HIV No increase No increase Realta (CH) No HIV Single cases Decrease No increase Vechta (D) No HIV No increase No increase Vierlande (D) No HIV Little change or reduction No increase No increase
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.

Editor's Notes

  1. I would like to give special thanks to Ralf Jurgens who has carried out this review and developed the key documents discussed here. As well as all experts and colleagues who provided their feedback and peer reviewed the drafts This series of E4A papers has also been endorsed by UNODC and UNAIDS The E4A papers on HIV/AIDS in prisons will soon become available on the WHO website at [insert address].
  2. Rates of HIV infection among prisoners in many countries are significantly higher than those in the general population.. HCV seroprevalence rates are even higher. Studies from around the world show that injecting drug use is a reality in many prisons and that most prisoners who inject will share injecting equipment. Even countries that have invested heavily in drug demand and drug supply reduction efforts in prisons have not been able to stop injecting drug use. Sexual activity, including rape and other forms of non-consensual sexual activity, also are reported from prisons around the world. Outbreaks of HIV infection have been documented in a number of prison systems (Scotland, Australia, Russia, Lithuania, Iran), demonstrating how rapidly HIV can spread in prison unless effective action is taken to prevent transmission. Since the early 1990s, various countries have introduced HIV programmes in prisons. However, many of them are small in scale, restricted to a few prisons, or exclude those interventions which are most effective. There is an urgent need to introduce comprehensive programmes, and to scale them up rapidly.
  3. Rates of HIV infection among prisoners in many countries are significantly higher than those in the general population.. HCV seroprevalence rates are even higher. Studies from around the world show that injecting drug use is a reality in many prisons and that most prisoners who inject will share injecting equipment. Even countries that have invested heavily in drug demand and drug supply reduction efforts in prisons have not been able to stop injecting drug use. Sexual activity, including rape and other forms of non-consensual sexual activity, also are reported from prisons around the world. Outbreaks of HIV infection have been documented in a number of prison systems (Scotland, Australia, Russia, Lithuania, Iran), demonstrating how rapidly HIV can spread in prison unless effective action is taken to prevent transmission. Since the early 1990s, various countries have introduced HIV programmes in prisons. However, many of them are small in scale, restricted to a few prisons, or exclude those interventions which are most effective. There is an urgent need to introduce comprehensive programmes, and to scale them up rapidly.
  4. Rates of HIV infection among prisoners in many countries are significantly higher than those in the general population.. HCV seroprevalence rates are even higher. Studies from around the world show that injecting drug use is a reality in many prisons and that most prisoners who inject will share injecting equipment. Even countries that have invested heavily in drug demand and drug supply reduction efforts in prisons have not been able to stop injecting drug use. Sexual activity, including rape and other forms of non-consensual sexual activity, also are reported from prisons around the world. Outbreaks of HIV infection have been documented in a number of prison systems (Scotland, Australia, Russia, Lithuania, Iran), demonstrating how rapidly HIV can spread in prison unless effective action is taken to prevent transmission. Since the early 1990s, various countries have introduced HIV programmes in prisons. However, many of them are small in scale, restricted to a few prisons, or exclude those interventions which are most effective. There is an urgent need to introduce comprehensive programmes, and to scale them up rapidly.
  5. France, Germany, Italy, Netherlands, Scotland, Sweden This table summarises the information we have on the prevalence of injecting and needle sharing in a number of countries, prisons and from a number of studies. While most study samples are relatively low, we see that injecting rates of up to 34or 74% of the prison population are reported. Even more worrying are the rates of needle sharing among drug injectors in prison settings of between 66-94% of those who inject.
  6. Because of the importance of HIV prevention and treatment in prisons, WHO has more recently commissioned a review of the effectiveness of HIV interventions in prisons which will be published this month and are also available on CD rom here at the WHO stand at the conference. Four key documents that consider the effectiveness of: (1) needle and syringe programmes and bleach (2) provision of condoms and prevention of rape, sexual assault and coercion (3) opioid substitution therapy and other drug dependence treatment, as well as some drug demand and supply reduction measures (4) HIV care, treatment and support In addition, there is a comprehensive paper on Effectiveness of Interventions to Manage HIV/AIDS in Prison Settings which, which will soon be published on our website in electronic format only. This comprehensive paper reviews, in addition to the interventions covered in the shorter papers, the evidence regarding other interventions that are part of a comprehensive approach to managing HIV/AIDS in prison settings. These papers contain the most comprehensive analysis of the international evidence related to HIV/AIDS in prisons undertaken to date , with hundreds of references. They complement work undertaken by UNODC , which is publishing HIV/AIDS Prevention, Care, Treatment, and Support in Prison Settings: A Framework for an Effective National Response ; and by the Health in Prison Project of WHO Europe, which last year published a Status Paper on Prisons, Drugs and Harm Reduction . In this presentation, I will focus on the areas covered by the four key documents of the evidence for action papers.
  7. The first intervention reviewed is targeted information and education, which is the least controversial measure. The evidence points to the conclusion that it providing information and education leads to increased knowledge. However, the evidence about its effect on risk behaviour in prison is limited. Peer education is more likely to be effective (Grinstead et al, 1999) Therefore, while essential it is not enough!
  8. The third key interventions on preventing sexual transmission available research and the experience of the many prison systems in different parts of the world in which condoms have been provided to prisoners for many years, without any reported problems, suggest that providing condoms in prisons is feasible in a wide range of prison settings. No prison system allowing condoms has reversed its policy , and none has reported security problems or any other relevant major negative consequences. In particular, it has been found that condom access is unobtrusive to the prison routine, represents no threat to security or operations , does not lead to an increase in sexual activity , and is accepted by most prisoners and correctional officers once it is introduced. Generally, only minor incidents of misuse such as water balloons, water fights and littering were recorded, and no incidents of drug concealment. Studies have not determined whether infections have been prevented due to condom provision in prison. However, there is evidence that prisoners use condoms to prevent infection during sexual activity when condoms are accessible in prison. It can therefore be considered likely that infections have been prevented. Finally, the evidence suggests that condoms are more likely to be used if they are easily and discreetly accessible to prisoners so that they can pick them up at various locations in the prison, without having to ask for them and without being seen by others. However, the evidence also shows that provision of condoms is not enough to address the risk of sexual transmission of HIV in prisons. Violence, including sexual abuse , is common in many prison systems. Measures to combat aggressive sexual behaviour such as rape, exploitation of vulnerable prisoners, and all forms of prisoner victimization are therefore as important as provision of condoms .
  9. Systematic evaluations of the effects of NSPs on risk behaviours and of their overall effectiveness in prisons were carried out in at least 10 projects in Switzerland, Germany, and Spain . There is evidence that NSPs are feasible in a wide range of prison settings, including in men’s and women’s prisons, prisons of all security levels, and small and large prisons. There is also evidence that providing clean needles and syringes is readily accepted by IDUs in prisons and More importantly that they contribute to a significant reduction of syringe sharing over time Which is if crucial importance for reducing HIV transmission .
  10. At the same time, there is no evidence to suggest that prison-based NSPs have serious, unintended negative consequences . In particular, they do not appear to lead to increased drug use or injecting , and needles are not used as weapons . Evaluations have found that NSPs in prisons actually facilitate referral of drug users to drug dependence treatment programmes.
  11. The review of the evidence suggests that In countries experiencing or threatened by an epidemic of HIV infections among IDUs, there is a need to introduce needle and syringe programmes in prisons and to expand implementation to scale as soon as possible. The higher the prevalence of injecting drug use and associated risk behaviour is in prison, the more urgent introduction of prison-based NSPs becomes. Prisoners need to have easy, confidential access to NSPs. Carefully evaluated pilot programmes of prison-based NSPs may be important in allowing the introduction of these programmes and to overcome objections against such programmes. However, they should not delay the expansion of the programmes, particularly where there already is evidence of high levels of injecting in prisons. Additional research about prison-based NSPs would be beneficial. In particular, more research in resource-poor systems outside Western Europe could allow for more rapid expansion of NSPs in these settings.
  12. In contrast to OST, other forms of drug dependence treatment have not usually been introduced in prison with HIV prevention as one of their objectives. It is therefore not surprising that there is little data on the effectiveness of these forms of treatment as an HIV prevention strategy . Good quality, appropriate, and accessible treatment has the potential of improving prison security, as well as the health and social functioning of prisoners, and it can reduce reoffending. Such treatment in prison can help reduce the amount of drug use in prisons and upon release. But there is a need for independent and systematic outcome evaluations of these interventions, and for examining their effectiveness in reducing injecting drug use and needle sharing. Other things may also be required. Research showing that the main reason why some prisoners take drugs when they are in custody is to combat boredom and alienation, and promote relaxation suggests a need for more purposeful activity within prisons. Ultimately, research suggests that reducing the number of people who are in prison because of problems related to their drug use must be a priority. Studies have shown that fear of arrest and sanctions is not a major factor in an individual’s decision on whether to use or deal drugs; and that there is little correlation between incarceration rates and drug use prevalence in particular countries or cities. As early as 1987, WHO, in a statement from the first Consultation on Prevention and Control of AIDS in Prisons, stated that “[g]overnments may … wish to review their penal admission policies, particularly where drug abusers are concerned, in the light of the AIDS epidemic and its impact on prisons.” Similarly, the new UNODC framework document on HIV/AIDS in prisons also suggests that “ action to reduce prison populations and prison overcrowding should accompany – and be seen as an integral component of – a comprehensive prison HIV/AIDS strategy.”
  13. In contrast to OST, other forms of drug dependence treatment have not usually been introduced in prison with HIV prevention as one of their objectives. It is therefore not surprising that there is little data on the effectiveness of these forms of treatment as an HIV prevention strategy . Good quality, appropriate, and accessible treatment has the potential of improving prison security, as well as the health and social functioning of prisoners, and it can reduce reoffending. Such treatment in prison can help reduce the amount of drug use in prisons and upon release. But there is a need for independent and systematic outcome evaluations of these interventions, and for examining their effectiveness in reducing injecting drug use and needle sharing. Other things may also be required. Research showing that the main reason why some prisoners take drugs when they are in custody is to combat boredom and alienation, and promote relaxation suggests a need for more purposeful activity within prisons. Ultimately, research suggests that reducing the number of people who are in prison because of problems related to their drug use must be a priority. Studies have shown that fear of arrest and sanctions is not a major factor in an individual’s decision on whether to use or deal drugs; and that there is little correlation between incarceration rates and drug use prevalence in particular countries or cities. As early as 1987, WHO, in a statement from the first Consultation on Prevention and Control of AIDS in Prisons, stated that “[g]overnments may … wish to review their penal admission policies, particularly where drug abusers are concerned, in the light of the AIDS epidemic and its impact on prisons.” Similarly, the new UNODC framework document on HIV/AIDS in prisons also suggests that “ action to reduce prison populations and prison overcrowding should accompany – and be seen as an integral component of – a comprehensive prison HIV/AIDS strategy.”
  14. Already in 1993 , WHO responded to growing evidence of HIV infection in prisons worldwide by issuing guidelines on HIV/AIDS in prisons. With regard to health care and prevention of HIV, these guidelines – as well as the recent UNODC framework document on HIV/AIDS in prisons – emphasized that “a ll prisoners have the right to receive health care, including preventive measures, equivalent to that available in the community without discrimination, in particular with respect to their legal status or nationality .” Thirteen years later, there is evidence that measures such as condom distribution, needle and syringe programmes, opioid substitution treatment, and provision of ART are feasible in prisons, and effective in promoting and protecting the health of prisoners and, ultimately, the community .